BUTANEDINITRILE, 2,3-DIMETHYL-2,3-BIS(2-METHYLPROPYL)-, 95%, 100mg

(R)-4-Phenyl-2-(quinolin-8-yl)-4,5-dihydrooxazole, 98%, 250mg

2-(Bromoacetyl)-6-methoxynaphthalene, 95+%, 5g

6-bromo[1,2,4]triazolo[4,3-a]pyrimidine, 95.0%, 1g

(Z)-N-[2-(1-methyl-1H-imidazol-2-yl)-1-phenylethylidene]hydroxylamine, 97%, 100mg

2-AMINO-2-(6-METHYLPYRIDIN-3-YL)ETHAN-1-OL, 95.0%, 250mg

2,2',2''-(Benzene-1,3,5-triyl)triacetic acid, 95+%, 1g

N1-((8R,9S,13S,14S,17S)-3-methoxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl)hexane-1,6-diamine, 98%, 100mg

4-[2-[(3-Ethyl-4-methyl-2-oxo-3-pyrrolin-1-yl)carboxamido]ethyl]benzenesulfonamide, 95.0%, 25g

2-(4-Acetylphenoxy)-6-chlorobenzonitrile, 97%, 1g

4-Chloro-3-fluorobenzonitrile, 96.0%, 10g

Silicagel LC60A 70-200 micron, 25kg

3-[[(3R)-4-(difluoromethyl)-2,2-difluoro-3-hydroxy-1,1-dioxo-3H-benzothiophen-5-yl]oxy]-5-fluoro-benzonitrile, 97, 5mg